PRPO Precipio Inc
Company Analysis
Latest News
🔴 Precipio is trading 5.6% down today as healthcare falls 2.19%
Precipio is trading 5.6% down at $25.73, primarily amid a healthcare-sector decline. - The stock fell from the September 8 close of $27.25; healthcare is down...
🟢 Precipio is trading 5.28% up today — No clear catalyst identified
Precipio is trading 5.28% up now at $27.50, with no clear company-specific catalyst identified. - No company-specific announcement dated September 2–4, 2026...
🔴 Precipio is trading 6.2% down today — no company-specific announcement identified
Precipio is trading 6.2% down at $24.50 after no company-specific announcement was identified for September 4, 2026. - Its investor-relations page lists...
🔴 Precipio is trading 5.1% down today with no clear company-specific catalyst identified
Precipio is trading 5.1% down now at $28.86, with no clear company-specific announcement or reliable news catalyst identified for August 27, 2026. - Its...
🔴 Precipio is trading 5.7% down today without a new company-specific catalyst
Precipio is trading 5.7% down at $27.75 after no new company-specific catalyst was identified for the August 21, 2026 decline. - The stock follows two strong...
🔴 Precipio is trading 8.26% down in pre-market; no company-specific catalyst identified
Precipio is trading 8.26% down in pre-market at $27.00 after no new company-specific explanation for the August 21 decline was identified; profit-taking or...
Precipio Hits Record Revenue and Turns Cash-Flow Positive — But Can a $50 Million Company Outrun Its Going-Concern Shadow?
Shares surged as Precipio Diagnostics, a tiny cancer-testing firm, posted the strongest quarter in its history — forcing investors to weigh accelerating growth...
🟢 Precipio is trading 11.56% up today after record Q2 revenue and positive adjusted EBITDA
Precipio is trading 11.56% up at $27.55 after investors continued reacting to its August 17, 2026, second-quarter results. - Revenue reached record $7.0...